Kangmei Pharmaceutical Co Ltd (600518) — Cash Flow-to-Debt Ratio
Kangmei Pharmaceutical Co Ltd (600518) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of CN¥219.96 Million could theoretically repay 0% of its total liabilities (CN¥6.46 Billion) in one year. Explore 600518 long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Kangmei Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for Kangmei Pharmaceutical Co Ltd across 26 annual periods. Also explore Kangmei Pharmaceutical Co Ltd (600518) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Kangmei Pharmaceutical Co Ltd (1999–2024)
Year-by-year debt coverage analysis for Kangmei Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 600518 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.06x | CN¥-427.63 Million | CN¥6.59 Billion | ▼ -47.2% |
| 2023 | -0.04x | CN¥-317.52 Million | CN¥7.20 Billion | ▲ +51.9% |
| 2022 | -0.09x | CN¥-749.96 Million | CN¥8.18 Billion | ▼ -360.3% |
| 2021 | 0.04x | CN¥214.21 Million | CN¥6.09 Billion | ▲ +49.3% |
| 2020 | 0.02x | CN¥1.03 Billion | CN¥43.74 Billion | ▼ -64.0% |
| 2019 | 0.07x | CN¥2.88 Billion | CN¥43.94 Billion | ▲ +909.4% |
| 2018 | 0.01x | CN¥305.62 Million | CN¥47.03 Billion | ▲ +104.9% |
| 2017 | -0.13x | CN¥-4.84 Billion | CN¥36.78 Billion | ▼ -308.8% |
| 2016 | 0.06x | CN¥1.60 Billion | CN¥25.44 Billion | ▲ +138.6% |
| 2015 | 0.03x | CN¥508.86 Million | CN¥19.27 Billion | ▼ -74.0% |
| 2014 | 0.10x | CN¥1.13 Billion | CN¥11.16 Billion | ▼ -38.1% |
| 2013 | 0.16x | CN¥1.67 Billion | CN¥10.22 Billion | ▲ +19.8% |
| 2012 | 0.14x | CN¥1.01 Billion | CN¥7.38 Billion | ▲ +42.4% |
| 2011 | 0.10x | CN¥574.96 Million | CN¥5.99 Billion | ▼ -52.9% |
| 2010 | 0.20x | CN¥669.19 Million | CN¥3.28 Billion | ▲ +231.9% |
| 2009 | 0.06x | CN¥119.47 Million | CN¥1.95 Billion | ▲ +2532.9% |
| 2008 | 0.00x | CN¥3.02 Million | CN¥1.29 Billion | ▼ -98.7% |
| 2007 | 0.18x | CN¥162.55 Million | CN¥882.71 Million | ▲ +106.6% |
| 2006 | 0.09x | CN¥68.32 Million | CN¥766.30 Million | ▼ -85.5% |
| 2005 | 0.62x | CN¥133.13 Million | CN¥216.45 Million | ▲ +168.0% |
| 2004 | 0.23x | CN¥78.52 Million | CN¥342.09 Million | ▼ -22.8% |
| 2003 | 0.30x | CN¥78.02 Million | CN¥262.25 Million | ▲ +32.6% |
| 2002 | 0.22x | CN¥53.47 Million | CN¥238.35 Million | ▲ +118.1% |
| 2001 | 0.10x | CN¥15.69 Million | CN¥152.51 Million | ▲ +31.4% |
| 2000 | 0.08x | CN¥9.96 Million | CN¥127.27 Million | ▼ -70.0% |
| 1999 | 0.26x | CN¥30.25 Million | CN¥115.77 Million | — |